These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12949692)

  • 21. [Apomorphine treatment of withdrawal symptoms in young opiate addicts].
    Gulmann NC; Kaldan B; Kobbernagal F
    Ugeskr Laeger; 1976 Oct; 138(42):2547-50. PubMed ID: 969008
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathogenic pharmacotherapy in the acute phase of the withdrawal syndrome in opium addiction].
    Miasnikov NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(3):48-9. PubMed ID: 11490448
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial.
    Moghadam MS; Alavinia M
    Pak J Pharm Sci; 2013 Sep; 26(5):985-9. PubMed ID: 24035957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy.
    Nikoo M; Nikoo N; Anbardan SJ; Amiri A; Vogel M; Choi F; Sepehry AA; Bagheri Valoojerdi AH; Jang K; Schütz C; Akhondzadeh S; Krausz M
    Addiction; 2017 Mar; 112(3):415-429. PubMed ID: 27740713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of Bam earthquake on substance users in the first 2 weeks: a rapid assessment.
    Movaghar AR; Goodarzi RR; Izadian E; Mohammadi MR; Hosseini M; Vazirian M
    J Urban Health; 2005 Sep; 82(3):370-7. PubMed ID: 16014876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute phase of drug withdrawal management by clothiapine (Entumin): a pilot project.
    Kraus JJ; Avnon MH; Stolerman I
    Int J Addict; 1980 Nov; 15(8):1191-7. PubMed ID: 6111543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial.
    Afzalimoghaddam M; Edalatifard M; Nejati A; Momeni M; Isavi N; Karimialavijeh E
    Curr Drug Abuse Rev; 2016; 9(2):142-147. PubMed ID: 28059034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep and some psychoactive drugs.
    Kay DC
    Psychosomatics; 1973; 14(2):108-24. PubMed ID: 4369175
    [No Abstract]   [Full Text] [Related]  

  • 31. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitussive activity of Anar.
    Epstein OI; Kovaleva VL; Zak MS
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():96-8. PubMed ID: 12949665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
    Mori T; Ito S; Matsubayashi K; Sawaguchi T
    Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heroin addiction: a treatable disease.
    Krepick DS; Long BL
    Nurs Clin North Am; 1973 Mar; 8(1):41-52. PubMed ID: 4487808
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative efficiency of Proproten-100 during the therapy of patients with alcoholism in the stage of therapeutic remission.
    Bokhan NA; Abolonin AF; Krylov EN; Vetlugina TP; Ivanova SA; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():171-5. PubMed ID: 12949690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentobarbital withdrawal and treatment in an infant in the pediatric cardiac intensive care unit.
    Weber GM; Smerling AJ; Saroyan JM
    J Clin Anesth; 2013 Feb; 25(1):62-5. PubMed ID: 23246494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new hypnotic from the benzodiazepin derivatives in the therapy of withdrawal symptoms in alcoholics].
    Kryspin-Exner K
    Wien Klin Wochenschr; 1966 Feb; 78(7):121-5. PubMed ID: 5983041
    [No Abstract]   [Full Text] [Related]  

  • 39. A Review Study on the Effect of Iranian Herbal Medicines on Opioid Withdrawal Syndrome.
    Ebrahimie M; Bahmani M; Shirzad H; Rafieian-Kopaei M; Saki K
    J Evid Based Complementary Altern Med; 2015 Oct; 20(4):302-9. PubMed ID: 25818661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of opium withdrawal using clonidine.
    Gehlot RS; Purohit DR; Shah DR
    J Assoc Physicians India; 1984 Mar; 32(3):268-9. PubMed ID: 6746525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.